Vidal, J., Flores, L., Jiménez, A., Pané, A., & de Hollanda, A. (2025). What is the evidence regarding the safety of new obesity pharmacotherapies. International Journal of Obesity, 49(3), 402. https://doi.org/10.1038/s41366-024-01488-5
Chicago-referens (17:e uppl.)Vidal, Josep, Lílliam Flores, Amanda Jiménez, Adriana Pané, och Ana de Hollanda. "What Is the Evidence Regarding the Safety of New Obesity Pharmacotherapies." International Journal of Obesity 49, no. 3 (2025): 402. https://doi.org/10.1038/s41366-024-01488-5.
MLA-referens (9:e uppl.)Vidal, Josep, et al. "What Is the Evidence Regarding the Safety of New Obesity Pharmacotherapies." International Journal of Obesity, vol. 49, no. 3, 2025, p. 402, https://doi.org/10.1038/s41366-024-01488-5.
Varning: dessa hänvisningar är inte alltid fullständigt riktiga.
